Europe Cannabis Industry & Marijuana Business News

Canadian marijuana shortage dampens Aurora’s international sales

(This story has been update to reflect a statement from Aurora on its Nordic 1 facility in Denmark. – Ed.) A shortfall of cannabis in Canada’s regulated market took a toll on the international sales of an industry leader, Aurora Cannabis, according to the company. The Alberta firm’s international medical cannabis sales rose nearly 40% […]

Read More

Northern Swan enlists major Democratic pols to boost Latin American cannabis push

Northern Swan, a New York-based marijuana investment group, installed two senior figures from the Democratic party to its advisory board to help navigate the company’s focus on Latin America. Bloomberg reported that the company appointed Tom Daschle, a former U.S Senate majority leader, and Joe Crowley, a prominent party member who last year lost a high-profile primary […]

Read More

IL gov touts adult-use marijuana plan, FL dispensary cap lawsuits, Euro MJ conference & more

Illinois Gov. J.B. Pritzker unveils a blueprint for recreational marijuana, lawsuits crop up in Florida around the state’s dispensary caps, a conference in Denmark highlights the growing international MJ space – plus other important news from around the cannabis industry. Recreational marijuana plan for Land of Lincoln The governor of Illinois revealed a plan to legalize […]

Read More

Netherlands prepares legal recreational cannabis cultivation experiment

The Netherlands is laying the groundwork to become the first country in Europe to allow commercial production of adult-use marijuana – although initially the program would be considered an experiment. Under the Dutch plan, a limited number of companies would be allowed to legally grow marijuana to supply coffee shops in the country that would, […]

Read More

5 key takeaways from MJBizDaily’s European Cannabis Symposium

With Europe fast becoming a cornerstone in the global medical marijuana industry, business leaders from dozens of countries descended on Copenhagen to discuss emerging opportunities in the burgeoning market. Capital markets, partnerships and more were on the docket Monday at Marijuana Business Daily’s inaugural European Cannabis Symposium in Denmark, one of the countries leading the medical […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More